tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TATA Health International Reports Interim Financial Results with Decreased Revenue

Story Highlights
  • TATA Health reported a significant drop in revenue and gross profit for the first half of 2024.
  • The company continues to face financial challenges, impacting its market position and stakeholder confidence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TATA Health International Reports Interim Financial Results with Decreased Revenue

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

TATA Health International Holdings Ltd. ( (HK:1255) ) just unveiled an update.

TATA Health International Holdings Limited, a company incorporated in the Cayman Islands, announced its interim financial results for the six months ending June 30, 2024. The company reported a decrease in revenue from HK$104,131,000 in 2023 to HK$72,309,000 in 2024, and a reduction in gross profit from HK$85,233,000 to HK$55,397,000. Despite a smaller loss before taxation compared to the previous year, the company still faced a loss of HK$5,130,000. The gross profit margin decreased from 81.9% to 76.6%, indicating challenges in maintaining profitability. The announcement reflects ongoing financial challenges for TATA Health International, impacting its market position and stakeholder confidence.

More about TATA Health International Holdings Ltd.

Technical Sentiment Signal: Sell

Current Market Cap: HK$72.85M

See more data about 1255 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1